Skip to main content
. 2019 Sep 30;90(Suppl 10):93–102. doi: 10.23750/abm.v90i10-S.8768

Table 1.

Polymorphisms identified from the literature as potential modifiers of neurotrophin-mediated neuroplastic activity

Gene Protein Class RefSeq Nucleotide change Amino acid change MAF (GnomAD) Ref
NGF Beta-nerve growth factor NTs rs6330 c.104C>T Ala35Val A=0.37015 (91127/246188) 39
BDNF Brain-derived neurotrophic factor NTs rs6265 c.196G>A Val66Met T=0.19437 (47821/246030) 40
NGFR Beta-nerve growth factor receptor NTs rs2072446 c.614C>T Ser205Leu T=0.05165 (12700/245884) 39
ADRB2 Beta-2 adrenergic receptor NTs rs1042713 c.46A>G Gly16Arg A=0.42081 (103492/245936) 45
ADRB2 Beta-2 adrenergic receptor NTs rs1042714 c.79C>G Gln27Glu G=0.31729 (78116/246198) 45
CNTF Ciliary neurotrophic factor NTs rs1800169 c.115-6G>A A=0.14950 (35961/240538) 46
MSTN Growth/differentiation factor 8 recovery rs1805086 c.458A>G Lys153Arg C=0.02732 (6704/245366) 53
ACTN3 Alpha-actinin-3 recovery rs1815739 c.1729C>T Arg577* T=0.46060 (113241/245854) 55
NTRK1 High affinity nerve growth factor receptor pain/NTs rs6334 c.1656G>A Gln552His A=0.22025 (54107/245664) 57
SCN9A Sodium channel protein type 9 subunit alpha pain rs6746030 c.3448C>T Arg1150Trp A=0.12050 (18374/152480) 60
COMT Catechol O-methyltransferase pain rs4680 c.322G>A Val158Met A=0.46252 (112239/242666) 66

Legend: NTs, neurotrophins; RefSeq, polymorhism accession number as recorded in the database of single nucleotide polymorphisms; MAF, minor alle frequency; Ref, reference.